Cytokinetics reported $-76086000 in Pre-Tax Profit for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US $ -14.79M 28.61M
Acceleron Pharma XLRN:US $ -70.45M 6.94M
Biogen BIIB:US $ 814.2M 255M
Brainstorm Cell Therapeutics BCLI:US $ -5.34M 0.93M
Bristol Myers Squibb BMY:US $ 5289M 67M
Capricor Therapeutics CAPR:US $ -3.93M 0.82M
Cytokinetics CYTK:US $ -76.09M 14.53M
Eisai 4523:JP Y 5564M 50219M
Eli Lilly And LLY:US $ 1470.5M 518.1M
Exelixis EXEL:US $ 53.26M 71.63M
Genocea Biosciences GNCA:US $ -3.62M 0.69M
Geron GERN:US $ -26.7M 2.88M
Halozyme Therapeutics HALO:US $ 74.11M 17.41M
Intra Cellular Therapies ITCI:US $ -76.93M 8.21M
IONIS PHARMACEUT IONS:US $ -84M 3M
Novartis NOVN:VX SF 4544M 120M
Regeneron Pharmaceuticals REGN:US $ 1822.2M 2076.1M